Search

everythinglearnresearchcommunity

for

Search:↓

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Corticosteroid pulse therapy is more effective for severe alopecia areata than combination therapy.

Platelet-rich plasma injections can effectively treat alopecia areata barbae.

New treatments focusing on immune pathways show promise for stubborn hair loss.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Laser therapy might help regrow hair in alopecia totalis better than steroids alone.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

White and yellow dots indicate severe female hair loss in dark skin.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Platelet-rich plasma treatment could potentially be an effective way to treat chronic alopecia areata with minimal side effects.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

Herbal medicine and acupuncture helped regrow hair and reduce pain in a patient with Alopecia Areata.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

The document concludes that fexofenadine reduces inflammation in chronic hives, cholestyramine helps half of pregnant women with itchy rashes, and relaxing incisions are a good alternative in facial surgery for the elderly.

The supplement significantly improves hair density and appearance in people with hair loss.

Videodermoscopy improves diagnosis of hair and scalp disorders and may reduce scalp biopsies.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Higher RBP4 levels found in people with two types of hair loss.